NEW YORK, June 1, 2012 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, announced today that Cavan M. Redmond has been appointed as its new Chief Executive Officer and as a member of its Board of Directors, effective May 31, 2012. Mr. Redmond, 51, joins WebMD from Pfizer Inc., the world's largest research-based pharmaceutical company, where he most recently served as Group President, Animal Health, Consumer Healthcare and Corporate Strategy and as a member of Pfizer's Executive Leadership Team. He was responsible for two diverse businesses while leading Pfizer's enterprise-wide Strategy, R&D Portfolio Management and Analysis, Global Commercial Operations and Continuous Improvement.
"Cavan brings unparalleled expertise and leadership in both biopharmaceutical and consumer healthcare to WebMD, and we are excited to welcome him to the WebMD team," said Martin J. Wygod, Chairman, WebMD. "He has a successful track record in identifying and leveraging new revenue opportunities, driving efficiency and establishing sustainable growth platforms. Along with our experienced management team, I have great confidence that Cavan will take WebMD to the next level. Cavan's proven ability to drive strategy and leverage the value of brands will be invaluable as WebMD continues to define and lead the market for digital health information."
Mr. Redmond has more than 20 years of healthcare experience encompassing a broad range of global healthcare businesses including biotechnology, pharmaceuticals, consumer healthcare and infant nutritionals. Mr. Redmond is a global healthcare strategist with a demonstrated ability to implement complex strategies in highly competitive and regulated markets. His strength in new product development, marketing, strategy and technology has resulted in a proven track record of building global brands, starting new businesses and reenergizing existing businesses. His biopharmaceutical experience also includes leading global strategic marketing, marketing research and analytics, new product marketing and multi-channel marketing programs. Prior to Pfizer's acquisition of Wyeth, Mr. Redmond served as the first Executive Vice President and General Manager of Wyeth's high-growth BioPharma Business Unit where he was responsible for the creation of the global biopharma business and grew the business significantly.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV